Tops & Flops Stocks
Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Avalo Therapeutics Inc. | 2.500% | - | - | - | - | - | - |
Avenue Therapeutics Inc. | 22.820% | - | - | - | - | - | - |
Aveo Pharmaceuticals Inc. | -1.910% | - | - | - | - | - | - |
Avid Bioservices Inc | 8.670% | 5.161% | 27.344% | -49.691% | 33.607% | -49.379% | 162.100% |
Axsome Therapeutics Inc | 4.280% | -0.680% | 7.841% | -3.680% | -2.421% | 43.553% | - |
Bavarian Nordic A/S | -0.090% | 3.903% | 10.693% | -20.934% | -7.489% | -36.023% | - |
BeiGene Ltd ADR | -1.330% | -0.662% | 12.782% | -33.036% | -9.091% | -41.860% | - |
Beijing Tong Ren Tang Chinese Medicine Co Ltd | 1.680% | 7.080% | 11.009% | -33.880% | -12.950% | 10.000% | -26.309% |
Bellicum Pharmaceuticals Inc. | -9.290% | - | - | - | - | - | - |
Biocryst Pharmaceuticals | 0.840% | 6.612% | 16.373% | -31.748% | -5.602% | -47.072% | -25.136% |
Biodelivery Sciences | -0.980% | - | - | - | - | - | - |
Biofrontera AG | -2.370% | -1.807% | -4.118% | -69.954% | -19.902% | -86.360% | -94.946% |
Biolife Solutions Inc | 14.550% | 15.244% | 19.620% | 13.855% | 26.846% | -21.901% | 27.668% |
Bionomics Ltd. | 12.120% | - | - | - | - | - | - |
Biospecifics Techs | -0.680% | - | - | - | - | - | - |
Biotest AG ST | 0.480% | 1.463% | -0.478% | -1.887% | -1.887% | 43.945% | 71.193% |
Biotest AG VZ | -1.080% | -0.714% | -3.136% | -13.125% | -10.323% | -4.138% | 26.651% |
BioTime Inc. | -1.300% | - | - | - | - | - | - |
Bioventix plc | 5.000% | 5.000% | -3.670% | 21.528% | 8.921% | 9.375% | - |
Boiron S.A. | 0.740% | 1.644% | -0.730% | -13.155% | -14.358% | -10.526% | -26.007% |
Bone Therapeutics S.A. | 5.360% | 1.724% | -63.580% | -95.000% | -92.625% | -99.745% | -99.839% |
B.R.A.I.N. Biotechnology Research and Information Network AG | 1.090% | -0.362% | -12.698% | -46.705% | -24.451% | -70.682% | -72.880% |
Brainstorm Cell | 19.620% | 43.062% | -9.747% | -80.315% | 115.517% | -82.143% | - |
Calithera Biosciences Inc. | - | - | - | - | - | - | - |
Cambrex Corp. | - | - | - | - | - | - | - |